CD44 and neoplasm: Kleverbring and colleagues compared bulk tumor cells and spheroids in ten primary samples, sorted CD44+/CD24− and CD44−/CD24− cells, and sorted aldehyde dehydrogenase positive (ALDH+) and negative (ALDH−) cells in two additional samples, by WES, and validated their findings by ultra-deep amplicon sequencing [14].